期刊論文／Journal Paper


[Selected Publications]:

1. Getu AA, Tigabu A, Zhou M, Lu J, Fodstad O, Tan M*. New frontiers in immune checkpoint B7-H3 (CD276) research and drug development. Molecular Cancer. 2023 Mar 2;22(1):43. (*Highly Cited Paper-Clarivate)

2. Lin CH, Chin Y, Zhou M, Sobol RW, Hung MC*, Tan M*. Protein lipoylation: mitochondria, cuproptosis, and beyond. Trends Biochem Sci. 2024 May 6:S0968-0004(24)00096-3.(www.cell.com/trends/biochemical-sciences)

3. Chin Y, Gumilar KE, Li XG, Tjokroprawiro BA, Lu CH, Lu J, Zhou M, Sobol RW, Tan M*. Targeting HSF1 for cancer treatment: mechanisms and inhibitor development. Theranostics. 2023 Apr 17;13(7):2281-2300.

4. Huang J, Tan M*. The role of ChatGPT in scientific communication: writing better scientific review articles. Am J Cancer Res. 2023 Apr 15;13(4):1148-1154. (*Highly Cited Paper-Clarivate)

5. Ayechew A Getu, Ming Zhou, Shi-Yuan Cheng, Ming Tan*. The mammalian Sterile 20-like kinase 4 (MST4) signaling in tumor progression: Implications for therapy. Cancer Letters. 2023 Apr 22;563:216183.

6. Liu Z, Zhang W, Phillips JB, Arora R, McClellan S, Li J, Kim JH, Sobol RW, Tan M*. Immunoregulatory protein B7-H3 regulates cancer stem cell enrichment and drug resistance through MVP-mediated MEK activation. Oncogene. 2019 Jan;38(1):88-102.

7. Lim S, Phillips JB, Madeira da Silva L, Zhou M, Fodstad O, Owen LB, Tan M*. Interplay between Immune Checkpoint Proteins and Cellular Metabolism. Cancer Research 2017 Mar 15;77(6):1245-1249.

8. Lim S, Liu H, Madeira da Silva L, Arora R, Liu Z, Phillips JB, Schmitt DC, Vu T, McClellan S, Lin Y, Lin W, Piazza GA, Fodstad O, Tan M*. Immunoregulatory Protein B7-H3 Reprograms Glucose Metabolism in Cancer Cells by ROS-Mediated Stabilization of HIF1α. Cancer Research 2016 Apr 15;76(8):2231-42.

9. Butler EB, Zhao Y, Munoz-Pinedo C, Lu J, Tan M*. Stalling the engine of resistance: targeting cancer metabolism to overcome therapeutic resistance. Cancer Research. 2013 May 1;73(9):2709-17.

10. Zhao Y, Liu H, Liu Z, Ding Y, Ledoux SP, Wilson GL, Voellmy R, Lin Y, Lin W, Nahta R, Liu B, Fodstad O, Chen J, Wu Y, Price JE, Tan M*. Overcoming trastuzumab resistance in breast cancer by targeting dysregulated glucose metabolism. Cancer Research. 2011 Jul 1;71(13):4585-97.

1 (Miao Peng)、(Shanshan Zhang)、(Pan Wu)、(Xiangchan Hou)、(Dan Wang)、(Junshang Ge)、(Hongke Qu)、(Chunmei Fan)、(Yujuan Zhou)、(Bo Xiang)、(Qianjin Liao)、(Ming Zhou)、譚明(Tan, Ming)、(Guiyuan Li)、(Wei Xiong)、(Pan Chen)*、(Zhaoyang Zeng)*、(Zhaojian Gong)*，Circular RNA circCLASP2 promotes nasopharyngeal carcinoma progression through binding to DHX9 to enhance PCMT1 translation，Molecular Cancer，2025 Mar，24(1):1-25，SCI
2 Khanisyah Er(Khanisyah Erza Gumilar)、(Birama Robby Indraprasta)、(Ach Salman Faridzi)、(Bagus M. Wibowo)、(Aditya Herlambang)、(Eccita Rahestyningtyas)、(Budi Irawan)、(Zulkarnain Tambunan)、(Ahmad Fadhli Bustomi)、(Bagus Ngurah Brahmantara)、(Zih-Ying Yu)、許祐誠(HSU YU-CHENG)、(Herlangga Pramuditya)、(Very Great Eka Putra)、(Hari Nugroho)、(Pungky Mulawardhana)、(Brahmana Askandar Tjokroprawiro)、(Tri Hedianto)、Ibrahim Haru(Ibrahim Haruna Ibrahim)、(Jingshan Huang)、(Dongqi Li)、(Chien-Hsing Lu)、楊哲彥(Yang, Jer-Yen)*、廖麗娜(Liao, Li-Na)*、譚明(Tan, Ming)*，Assessment of Large Language Models (LLMs) in Decision-Making Support for Gynecologic Oncology，Computational and Structural Biotechnology Journal，2024 Dec，23():4019-4026，SCI
3 (Changning Xue)、(Hanbing Meng)、(Weihong Niu)、(Mengna Li)、(Jianxia Wei)、(Shipeng Chen)、(Lemei Zheng)、(Yumei Duan)、(Hongyu Deng)、(Faqing Tang)、(Songqing Fan)、譚明(Tan, Ming)、(Wei Xiong)、(Ming Zhou)*，TRIM28 promotes tumor growth and metastasis in breast cancer by targeting the BRD7 protein for ubiquitination and degradation，CELLULAR ONCOLOGY，2024 Oct，47(5):1973-1993，SCI
4 (Qing Zhou)、(Yilin Guo)、(Ziying Tian)、(Yanbing Qiu)、(Ying Liu)、(Qingluan Liu)、(Yijun Liu)、(Yuqin Yang)、(Lei Shi)、(Xiayu Li)、(Ge Gao)、(Songqing Fan)、(Zhaoyang Zeng)、(Wei Xiong)、譚明(Tan, Ming)、(Guiyuan Li)、(Wenling Zhang)*，PLUNC inhibits invasion and metastasis in nasopharyngeal carcinoma by inhibiting NLRP3 inflammasome activation，BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE，2024 Oct，1870(7):1-14，SCI
5 (Junshang Ge)、(Yi Meng)、(Jiayue Guo)、(Pan Chen)、(Jie Wang)、(Lei Shi)、(Dan Wang)、(Hongke Qu)、(Pan Wu)、(Chunmei Fan)、(Shanshan Zhang)、(Qianjin Liao)、(Ming Zhou)、(Bo Xiang)、(Fuyan Wang)、譚明(Tan, Ming)、(Zhaojian Gong)*、(Wei Xiong)*、(Zhaoyang Zeng)*，Human papillomavirus-encoded circular RNA circE7 promotes immune evasion in head and neck squamous cell carcinoma，Nature Communications，2024 Oct，15(1):1-18，SCI
6 (Feiyang Wang)、(Qiudi Liao)、(Zihao Qin)、(Jingyi Li)、(Qingqing Wei)、(Mengna Li)、(Hongyu Deng)、(Wei Xiong)、譚明(Tan, Ming)、(Ming Zhou)*，Autophagy: a critical mechanism of N6-methyladenosine modification involved in tumor progression and therapy resistance，Cell Death & Disease，2024 Oct，15(10):1-15，SCI
7 (Joshua B. Phillips)、(Seong-Sik Park)、林承翰(LIN, CHENG-HAN)、(Juyoung Cho)、(Sangbin Lim)、(Ritu Aurora)、(Jin-Hwan Kim)、(Anusha Angajala)、(Bohye Park)、(Joshua K. Stone)、(Bin Wang)、(Andrea G. Kahn)、(Ssang-Taek Steve Lim)、(Jung-Hyun Kim)*、(Eun-Young Erin Ahn)*、譚明(Tan, Ming)*，SON is an essential RNA splicing factor promoting ErbB2 and ErbB3 expression in breast cancer，BRITISH JOURNAL OF CANCER，2024 Sep，():1-13，SCI
8 林承翰(LIN, CHENG-HAN)、(Ye Chin)、(Ming Zhou)、(Robert W. Sobol)、洪明奇(Mien-Chie Hung)*、譚明(Tan, Ming)*，Protein lipoylation: mitochondria, cuproptosis, and beyond，TRENDS IN BIOCHEMICAL SCIENCES，2024 Aug，49(8):729-744，SCI
9 Khanisyah Er(Khanisyah Erza Gumilar)、(Birama R. Indraprasta)、許祐誠(Hsu, Yu-Cheng)、游子瑩(YIOU, ZIH-YING)、陳鴻(Chen, Hong)、(Budi Irawan)、(Zulkarnain Tambunan)、(Bagus M. Wibowo)、(Hari Nugroho)、(Brahmana A. Tjokroprawiro)、(Erry G. Dachlan)、(Pungky Mulawardhana)、(Eccita Rahestyningtyas)、(Herlangga Pramuditya)、(Very Great E. Putra)、(Setyo T. Waluyo)、(Nathan R. Tan)、(Royhaan Folarin)、Ibrahim Haru(IBRAHIM HARUNA IBRAHIM)、林承翰、洪岱佑(Hung, Tai-Yu)、(Ting-Fang Lu)、(Yen-Fu Chen)、(Yu-Hsiang Shih)、(Shao-Jing Wang)、(Jingshan Huang)、(Clayton C. Yates)、(Chien-Hsing Lu)*、廖麗娜(Liao, Li-Na)*、譚明(Tan, Ming)*，Disparities in medical recommendations from AI-based chatbots across different countries/regions，Scientific Reports，2024 Jul，14(1):1-10，SCI
10 Khanisyah Er(Khanisyah Erza Gumilar)、(Bayu Priangga)、(Chien-Hsing Lu)、(Erry Gumilar Dachlan)、譚明(Tan, Ming)*，Iron metabolism and ferroptosis: A pathway for understanding preeclampsia，BIOMEDICINE & PHARMACOTHERAPY，2023 Nov，167():115565，SCI
11 Khanisyah Er(Khanisyah Erza Gumilar)、(Yeh Chin)、Ibrahim Haru(IBRAHIM HARUNA IBRAHIM)、(Brahmana A. Tjokroprawiro)、楊哲彥(Yang, Jer-Yen)、(Ming Zhou)、(Natalie R. Gassman)、譚明(Tan, Ming)*，HSF1 Inhibition: A Novel Anti-Cancer Strategy with Promise for Precision Oncology，Cancers，2023 Oct，10(26):，SCI
12 Khanisyah Er(Khanisyah Erza Gumilar)、(Yeh Chin)、Ibrahim Haru(Ibrahim Haruna Ibrahim)、(Brahmana A. Tjokroprawiro)、楊哲彥(Yang, Jer-Yen)、(Ming Zhou)、(Natalie R. Gassman)、譚明(Tan, Ming)*，Heat Shock Factor 1 Inhibition: A Novel Anti-Cancer Strategy with Promise for Precision Oncology，Cancers，2023 Oct，15(21):5167，SCI
13 (Mengna Li)、(Yumei Duan)、(Jianxia Wei)、(Shipeng Chen)、(Changning Xue)、(Lemei Zheng)、(Hongyu Deng)、(Songqing Fan)、(Wei Xiong)、(Guiyuan Li)、譚明(Tan, Ming)、(Faqing Tang)、(Kelin She)*、(Ming Zhou)*，Yin Yang 1 suppresses tumor invasion and metastasis in nasopharyngeal carcinoma by negatively regulating eIF4E transcriptional activity and expression，American Journal of Cancer Research，2023 Aug，13(8):3763-3780，SCI
14 Getu Ayechew(GETU AYECHEW ADERA)、(Ming Zhou)、(Shi-Yuan Cheng)、譚明(Tan, Ming)*，The mammalian Sterile 20-like kinase 4 (MST4) signaling in tumor progression: Implications for therapy，CANCER LETTERS，2023 Jun，563():1-8，SCI
15 鄭方茹(Cheng, Fang-Ju)、何建宜(Chien-Yi Ho)、李宗勳(Tzong?Shiun Li)、陳曄(Yeh Chen)、葉屹倫(Yeh, Yi-Lun)、魏雅鈴(Ya-Ling Wei)、Huynh Kieu T(Huynh Kieu Thanh)、陳柏融(Chen, Bo-Rong)、(Hung?Yu Ko)、薛晨希(Chen?Si Hsueh)、譚明(Tan, Ming)、吳永昌(Yang-Chang Wu)、黃慧琪(Hui-Chi Huang)、湯智昕(Chih-Hsin Tang)、陳家弘(Chia-Hung Chen)、涂智彥(Chih-Yen Tu)、黃偉謙(Huang, Wei-Chien)*，Umbelliferone and eriodictyol suppress the cellular entry of SARS-CoV-2，Cell and Bioscience，2023 Jun，13(118):，SCI
16 (Jingshan Huang)、譚明(Tan, Ming)*，The role of ChatGPT in scientific communication: writing better scientific review articles，American Journal of Cancer Research，2023 Apr，13(4):1148-1154，SCI
17 靳業(CHIN, YEH)、Khanisyah Er(Khanisyah Erza Gumilar)、李興國(Li, Xing-Guo)、(Brahmana A. Tjokroprawiro)、(Chien-Hsing Lu)、(Jianrong Lu)、(Ming Zhou)、(Robert W. Sobol)、譚明(Tan, Ming)*，Targeting HSF1 for cancer treatment: mechanisms and inhibitor development，Theranostics，2023 Apr，13(7):2281-2300，SCI
18 Getu Ayechew(GETU AYECHEW ADERA)、Abiye Tigabu(ABIYE TIGABU MOLLA)、(Ming Zhou)、(Jianrong Lu)、(Oystein Fodstad)、譚明(Tan, Ming)*，New frontiers in immune checkpoint B7-H3 (CD276) research and drug development，Molecular Cancer，2023 Mar，22(1):，SCI
19 (Timofey Lebedev)、Rubina Kousa(RUBINA KOUSAR)、Bbumba Patri(BBUMBA PATRICK)、Muhammad Usa(MUHAMMAD USAMA)、(Meng-Kuei Lee)、譚明(Tan, Ming)、李興國(Li, Xing-Guo)*，Targeting ARID1A-Deficient Cancers: An Immune-Metabolic Perspective，Cells，2023 Mar，12(6):952，SCI
20 (Mengna Li)、(Yanmei Wei)、(Yukun Liu)、(Jianxia Wei)、(Xiangting Zhou)、(Yumei Duan)、(Shipeng Chen)、(Changning Xue)、(Yuting Zhan)、(Lemei Zheng)、(Hongyu Deng)、(Faqing Tang)、(Songqing Fan)、(Wei Xiong)、(Guiyuan Li)、譚明(Tan, Ming)、(Ming Zhou)*，BRD7 inhibits enhancer activity and expression of BIRC2 to suppress tumor growth and metastasis in nasopharyngeal carcinoma，Cell Death & Disease，2023 Feb，14():121，SCI
21 (Ritu Arora)、(Jin-Hwan Kim)、Getu Ayechew(GETU AYECHEW ADERA)、(Anusha Angajala)、(Yih-Lin Chen)、(Bin Wang)、(Andrea G. Kahn)、陳鴻(Chen, Hong)、(Latif Reshi)、(Jianrong Lu)、(Wenling Zhang)、(Ming Zhou)、譚明(Tan, Ming)*，MST4: a Potential Oncogene and Therapeutic Target in Breast Cancer，Cells，2022 Dec，11(24):4057，SCI
22 (Anusha Angajala)、(Hughley Raymond)、(Aliyu Muhammad)、(Md Shakir Uddin Ahmed)、(Saadia Haleema)、(Monira Haque)、(Honghe Wang)、(Moray Campbell)、(Rachel Martini)、(Balasubramanian Karanam)、(Andrea G. Kahn)、(Deepa Bedi)、(Melissa Davis)、譚明(Tan, Ming)、(Windy Dean-Colomb)、(Clayton Yates)*，MicroRNAs within the Basal-like signature of Quadruple Negative Breast Cancer impact overall survival in African Americans，Scientific Reports，2022 Dec，12(1):22178，SCI
23 (Mingwei Liang)、(Jennifer W. Li)、(Huacheng Luo)、(Sarah Lulu)、(Ozlem Calbay)、(Anitha Shenoy)、譚明(Tan, Ming)、(Brian K. Law)、(Shuang Huang)、(Tsan Sam Xiao)、(Hao Chen)、(Lizi Wu)、(Jia Chang)、(Jianrong Lu)*，Epithelial-Mesenchymal Transition Suppresses AMPK and Sensitizes Cancer Cells to Pyroptosis under Energy Stress，Cells，2022 Jul，11(14):，SCI
24 (Huacheng Luo)、(Qin Yu)、(Yang Liu)、(Ming Tang)、(Mingwei Liang)、(Dingpeng Zhang)、(Tsan Sam Xiao)、(Lizi Wu)、譚明(Tan, Ming)、(Yijun Ruan)、(Jorg Bungert)、(Jianrong Lu)*，LATS kinase-mediated CTCF phosphorylation and selective loss of genomic binding，Science Advances，2020 Feb，6(8):，SCI
25 (Yi Liu)、(Qingluan Liu)、(Shumin Chen)、(Yijun Liu)、(Yumei Huang)、(Pan Chen)、(Xiayu Li)、(Ge Gao)、(Keqian Xu)、(Songqing Fan)、(Zhaoyang Zeng)、(Wei Xiong)、譚明(Tan, Ming)、(Guiyuan Li)、(Wenling Zhang)*，APLNR is involved in ATRA-induced growth inhibition of nasopharyngeal carcinoma and may suppress EMT through PI3K-Akt-mTOR signaling，FASEB JOURNAL，2019 Nov，33(11):11959-11972，SCI
26 (Stone JK)、(Kim JH)、Vukadin L、(Richard A)、(Giannini HK)、(Lim STS)、譚明(Tan, Ming)、(Ahn EYE)*，Hypoxia induces cancer cell-specific chromatin interactions and increases MALAT1 expression in breast cancer cells，JOURNAL OF BIOLOGICAL CHEMISTRY，2019 Jul，294(29):11213-11224，SCI
27 (Yao Zhou)、(Weihong Niu)、(Yanwei Luo)、(Hui Li)、(Yong Xie)、(Heran Wang)、(Yukun Liu)、(Songqing Fan)、(Zheng Li)、(Wei Xiong)、(Xiaoling Li)、(Caiping Ren)、譚明(Tan, Ming)、(Guiyuan Li)、(Ming Zhou)*，p53/Lactate dehydrogenase A axis negatively regulates aerobic glycolysis and tumor progression in breast cancer expressing wild-type p53，CANCER SCIENCE，2019 Mar，110(3):939-949，SCI
28 (Zixing Liu)、(Wenling Zhang)、(Joshua B Phillips)、(Ritu Arora)、(Steven McClellan)、(Jiangfeng Li)、(Jin-Hwan Kim)、(Robert W Sobol)、譚明(Tan, Ming)*，Immunoregulatory protein B7-H3 regulates cancer stem cell enrichment and drug resistance through MVP-mediated MEK activation，ONCOGENE，2019 Jan，38(1):88-102，SCI
29 (Anusha Angajala)、(Sangbin Lim)、(Joshua B Phillips)、(Jin-Hwan Kim)、(Clayton Yates)、(Zongbing You)、譚明(Tan, Ming)*，Diverse Roles of Mitochondria in Immune Responses: Novel Insights Into Immuno-Metabolism，Frontiers in Immunology，2018 Aug，9():1605，SCI
30 (Karine Flem-Karlsen)、(Oystein Fodstad)、譚明(Tan, Ming)、(Caroline E Nunes-Xavier)*，B7-H3 in Cancer - Beyond Immune Regulation，Trends in Cancer，2018 Jun，4(6):401-404，SCI
31 (Floros KV)、(Lochmann TL)、(Hu B)、(Monterrubio C)、(Hughes MT)、(Wells JD)、(Morales CB)、(Ghotra MS)、(Costa C)、(Souers AJ)、(Boikos SA)、(Leverson JD)、譚明(Tan, Ming)、(Serra V)、(Koblinski JE)、(Arribas J)、(Prat A)、(Pare L)、(Miller TW)、(Dozmorov MG)、(Harada H)、(Windle BE)、(Scaltriti M)、(Faber AC)*，Coamplification of miR-4728 protects HER2-amplified breast cancers from targeted therapy.，PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA，2018 Mar，115(11):E2594-E2603，SCI
32 (Lim S)、(Phillips JB)、(Madeira da Silva L)、(Zhou M)、(Fodstad O)、(Owen LB)*、譚明(Tan, Ming)*，Interplay between Immune Checkpoint Proteins and Cellular Metabolism.，CANCER RESEARCH，2017 Mar，77(6):1245-1249，SCI
33 (Huang T)、(Alvarez AA)、(Pangeni RP)、(Horbinski CM)、(Lu S)、(Kim SH)、(James CD)、(J Raizer J)、(A Kessler J)、(Brenann CW)、(Sulman EP)、(Finocchiaro G)、譚明(Tan, Ming)、(Nishikawa R)、(Lu X)、(Nakano I)、(Hu B)、(Cheng SY)*，A regulatory circuit of miR-125b/miR-20b and Wnt signalling controls glioblastoma phenotypes through FZD6-modulated pathways.，Nature Communications，2016 Oct，7():12885，SCI
34 (Lim S)、(Liu H)、(Madeira da Silva L)、(Arora R)、(Liu Z)、(Phillips JB)、(Schmitt DC)、(Vu T)、(McClellan S)、(Lin Y)、(Lin W)、(Piazza GA)、(Fodstad O)、譚明(Tan, Ming)*，Immunoregulatory Protein B7-H3 Reprograms Glucose Metabolism in Cancer Cells by ROS-Mediated Stabilization of HIF1α.，CANCER RESEARCH，2016 Apr，76(8):2231-2242，SCI